We provide an extensive overview of current structural insights on the leptin–ObR interface and ObR activation, coupling to signaling pathways and their negative regulation, and leptin functioning under normal and pathophysiological conditions (obesity, autoimmunity, cancer, ... ). The gene discussed is LEPROT; the disease is obesity due to melanocortin 4 receptor deficiency.